Minimally invasive gynecologic surgeons aim to improve patients’ quality of life
The team at EvergreenHealth Women’s Specialty Care, Gynecology treats complex conditions, like endometriosis and fibroids. Sponsored by EvergreenHealth.
ImmunityBio's Cash Burn And Dilution Dampen Anktiva's Potential
ImmunityBio is conducting trials of Anktiva in various cancers, including NSCLC and ovarian cancer. Click here to read an analysis of IBRX stock now.
Nature3 天
The management of superficial bladder cancer
Early radical cystectomy can be beneficial and should be performed in patients with refractory T1 tumors or carcinoma in situ before progression to muscle invasion. In this Review I present an ...
PharmiWeb4 天
Endometriosis Treatment Market Projected to Reach $3.1 Billion by 2034: Advancements in ...
The market for endometriosis treatment is projected to attain a value of US$ 3.1 billion by 2034. According to Transparency ...
AZN's Bladder Cancer sBLA for Imfinzi Gets FDA's Priority Tag
AstraZeneca AZN announced that the FDA has accepted and granted priority review to its supplemental biologics license application (sBLA) seeking expanded use of its blockbuster drug, Imfinzi ...
Priority FDA review given to AstraZeneca’s Imfinzi sBLA for MIBC
The US Food and Drug Administration (FDA) has granted priority review to AstraZeneca's supplemental biologics licence ...
UroToday6 天
SUO 2024: Emerging Therapeutics: Combination Therapy in Neoadjuvant Setting
(UroToday.com) The 2024 Society of Urologic Oncology (SUO) annual meeting held in Dallas, between December 3 and December 6, ...
EuropaWire6 天
AstraZeneca’s Imfinzi Granted Priority Review by FDA for Groundbreaking Perioperative ...
AstraZeneca’s Imfinzi (durvalumab) has been granted Priority Review by the FDA for the treatment of muscle-invasive bladder cancer (MIBC), pote ...